These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20716489)

  • 1. FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.
    Ziegler N; Bätz J; Zabel U; Lohse MJ; Hoffmann C
    Bioorg Med Chem; 2011 Feb; 19(3):1048-54. PubMed ID: 20716489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FRET-based detection of M1 muscarinic acetylcholine receptor activation by orthosteric and allosteric agonists.
    Markovic D; Holdich J; Al-Sabah S; Mistry R; Krasel C; Mahaut-Smith MP; Challiss RA
    PLoS One; 2012; 7(1):e29946. PubMed ID: 22272263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence resonance energy transfer-based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation.
    Maier-Peuschel M; Frölich N; Dees C; Hommers LG; Hoffmann C; Nikolaev VO; Lohse MJ
    J Biol Chem; 2010 Mar; 285(12):8793-800. PubMed ID: 20083608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.
    Zürn A; Zabel U; Vilardaga JP; Schindelin H; Lohse MJ; Hoffmann C
    Mol Pharmacol; 2009 Mar; 75(3):534-41. PubMed ID: 19106230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells.
    Hoffmann C; Gaietta G; Bünemann M; Adams SR; Oberdorff-Maass S; Behr B; Vilardaga JP; Tsien RY; Ellisman MH; Lohse MJ
    Nat Methods; 2005 Mar; 2(3):171-6. PubMed ID: 15782185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential coupling of muscarinic M1, M2, and M3 receptors to phosphoinositide hydrolysis in urinary bladder and longitudinal muscle of the ileum of the mouse.
    Tran JA; Matsui M; Ehlert FJ
    J Pharmacol Exp Ther; 2006 Aug; 318(2):649-56. PubMed ID: 16675640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor.
    Sykes DA; Dowling MR; Charlton SJ
    Mol Pharmacol; 2009 Sep; 76(3):543-51. PubMed ID: 19498041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
    Jakubík J; El-Fakahany EE; Dolezal V
    Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice.
    Gautam D; Heard TS; Cui Y; Miller G; Bloodworth L; Wess J
    Mol Pharmacol; 2004 Aug; 66(2):260-7. PubMed ID: 15266016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A flow cytometric method to detect protein-protein interaction in living cells by directly visualizing donor fluorophore quenching during CFP-->YFP fluorescence resonance energy transfer (FRET).
    He L; Olson DP; Wu X; Karpova TS; McNally JG; Lipsky PE
    Cytometry A; 2003 Oct; 55(2):71-85. PubMed ID: 14505312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand regulation of the quaternary organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogeneous time-resolved FRET.
    Alvarez-Curto E; Ward RJ; Pediani JD; Milligan G
    J Biol Chem; 2010 Jul; 285(30):23318-30. PubMed ID: 20489201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of Gq protein stabilizes the activated state of the muscarinic receptor type 1.
    Tateyama M; Kubo Y
    Neuropharmacology; 2013 Feb; 65():173-81. PubMed ID: 23085334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor.
    Tahtaoui C; Parrot I; Klotz P; Guillier F; Galzi JL; Hibert M; Ilien B
    J Med Chem; 2004 Aug; 47(17):4300-15. PubMed ID: 15294002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric measurement of fluorescence (Förster) resonance energy transfer from cyan fluorescent protein to yellow fluorescent protein using single-laser excitation at 458 nm.
    He L; Bradrick TD; Karpova TS; Wu X; Fox MH; Fischer R; McNally JG; Knutson JR; Grammer AC; Lipsky PE
    Cytometry A; 2003 May; 53(1):39-54. PubMed ID: 12701131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the activation kinetics of the M3 acetylcholine receptor and a constitutively active mutant receptor in living cells.
    Hoffmann C; Nuber S; Zabel U; Ziegler N; Winkler C; Hein P; Berlot CH; Bünemann M; Lohse MJ
    Mol Pharmacol; 2012 Aug; 82(2):236-45. PubMed ID: 22564786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of muscarinic m5 receptors inhibits recombinant KCNQ2/KCNQ3 K+ channels expressed in HEK293T cells.
    Guo J; Schofield GG
    Eur J Pharmacol; 2003 Feb; 462(1-3):25-32. PubMed ID: 12591092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.
    Kukkonen JP; Näsman J; Rinken A; Dementjev A; Akerman KE
    Biochem Biophys Res Commun; 1998 Feb; 243(1):41-6. PubMed ID: 9473476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.